HHS reports how initial states plan to use rapid COVID-19 tests
The Department of Health and Human Services yesterday released initial data on how states and territories plan to use their share of 100 million rapid point-of-care tests for the COVID-19 virus, which the agency began distributing last month.
The initial data includes 32 states and the District of Columbia. The Food and Drug Administration in August authorized laboratories certified to perform moderate, high or waived complexity tests under the Clinical Laboratory Improvement Amendment to use the Abbot BinaxNOW antigen test to detect SARS-CoV-2 in nasal swabs from individuals whose health care provider suspects they have COVID-19 within seven days of symptom onset.
Related News Articles
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…